Overall rank by patents
#39,858
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61D (VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS).
The verdict
Desvac holds 6 US patents across 5 technology areas, rank #39,858 of 50,000 tracked assignees.
Desvac has been granted 6 US utility patents between 2018 and 2025, placing Desvac at rank #39,858 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.3 claims per patent with primary concentration in A61D (VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS). As a Foreign Corporation, Desvac is one of the more focused assignees in the PatentsView dataset. By volume, Desvac sits between Dept. Of Electrical Engineering, National Changhua University Of Education (6 patents, rank #39,854) and Diacarta Inc. (6 patents, rank #39,862) - the closest US assignees by grant volume. The composite Innovation Score of 29.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 2 in the 2015–2019 window, a +100% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Desvac's 13.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Desvac against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Dept. of Electrical Engineering, National Changhua University of Education
6 patents
DermaGenesis, LLC
6 patents
Desco Industries, Inc.
6 patents
Desert Aire Corp.
6 patents
Detec Systems LLC
6 patents
Develco Pharma Schweiz AG
6 patents
Devil Dog Concepts, LLC
6 patents
DiaCarta Inc.
6 patents
Desvac
6 patents
What this shows Desvac holds 6 patents at rank #39,858, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #39,858 in granted patent volume.
Other assignees with the most granted patents in Desvac's primary technology class.
Desvac's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 70% higher than 30% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 16.7% |
| 2019 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2023 | 1 | 16.7% |
| 2025 | 1 | 16.7% |
Top 5 of 5 technology areas
Overall rank by patents
#39,858
Across all tracked assignees
29.3 out of 100
How to use this portfolio
Desvac's 6 grants land it in the top 70% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.